Cargando…
CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives
CRISPR-Cas9 is a Nobel Prize-winning robust gene-editing tool developed in the last decade. This technique enables a stable genetic engineering method with high precision on the genomes of all organisms. The latest advances in the technology include a genome library screening approach, which can det...
Autores principales: | Chan, Yau-Tuen, Lu, Yuanjun, Wu, Junyu, Zhang, Cheng, Tan, Hor-Yue, Bian, Zhao-xiang, Wang, Ning, Feng, Yibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065202/ https://www.ncbi.nlm.nih.gov/pubmed/35547744 http://dx.doi.org/10.7150/thno.71144 |
Ejemplares similares
-
Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis
por: Chan, Yau-tuen, et al.
Publicado: (2023) -
Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
por: Lu, Yuanjun, et al.
Publicado: (2020) -
The Role of Protein SUMOylation in Human Hepatocellular Carcinoma: A Potential Target of New Drug Discovery and Development
por: Yuan, Hongchao, et al.
Publicado: (2021) -
Genipin-activating PPARγ impedes CCR2-mediated macrophage infiltration into postoperative liver to suppress recurrence of hepatocellular carcinoma
por: Wu, Junyu, et al.
Publicado: (2023) -
Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era?
por: Chan, Yau-Tuen, et al.
Publicado: (2020)